Early approval of Alnylam’s gene-silencing drug in question
By Saumya Joseph and Manojna Maddipatla (Reuters) – Alnylam Pharmaceuticals Inc said on Thursday it might have to hold off on plans to seek an accelerated approval for its gene-silencing drug, which showed effectiveness in...
Read More